Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice.
ABR
DPOAE
auditory function
cochelotoxicity
furosemide
gentamicin
hair cells
kanamycin
mouse
ototoxicity
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
04
12
2018
accepted:
23
05
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
19
7
2019
Statut:
ppublish
Résumé
Aminoglycoside ototoxicity is common in clinical practice but reliable protective agents currently do not exist. Aminoglycoside regimens causing ototoxicity in different laboratory animals are under investigation. The assessment method used most commonly to determine auditory effects is the auditory brainstem response (ABR). Distortion product otoacoustic emissions (DPOAE) have been used less frequently. A precise recommendation on the specific method to assess peripheral auditory function before and after aminoglycoside toxicity in mice does not exist. In order to evaluate various mouse models for ototoxic injury caused by various aminoglycoside regimens, there is a need for performing preliminary tests in small cohorts before large experiments. The aim of our study was to investigate different aminoglycoside regimens that cause substantial ototoxic damage
Identifiants
pubmed: 31316607
doi: 10.3892/etm.2019.7687
pii: ETM-0-0-7687
pmc: PMC6601143
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1123-1130Références
Hear Res. 1999 Apr;130(1-2):1-6
pubmed: 10320095
Audiol Neurootol. 2000 Jan-Feb;5(1):3-22
pubmed: 10686428
Hear Res. 2001 Aug;158(1-2):165-78
pubmed: 11506949
Hear Res. 2001 Nov;161(1-2):72-80
pubmed: 11744283
Hear Res. 2002 Sep;171(1-2):111-118
pubmed: 12204355
Hear Res. 2003 Nov;185(1-2):90-6
pubmed: 14599696
Food Chem Toxicol. 2004 Feb;42(2):261-74
pubmed: 14667472
Hear Res. 2004 Jan;187(1-2):131-3
pubmed: 14698094
Am J Physiol Renal Physiol. 2005 May;288(5):F881-96
pubmed: 15821253
Hear Res. 2007 Sep;231(1-2):1-12
pubmed: 17475424
Neuromolecular Med. 2007;9(3):205-15
pubmed: 17914179
J Assoc Res Otolaryngol. 2008 Mar;9(1):44-64
pubmed: 18057986
Toxicology. 2008 Jul 30;249(2-3):91-6
pubmed: 18514377
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):700-3
pubmed: 19128679
J Assoc Res Otolaryngol. 2009 Sep;10(3):321-40
pubmed: 19373512
J Assoc Res Otolaryngol. 2009 Dec;10(4):525-44
pubmed: 19644644
Lab Anim. 2010 Apr;44(2):124-31
pubmed: 19858169
Toxicol Lett. 2010 Mar 1;193(1):41-9
pubmed: 20015469
Hear Res. 2011 Feb;272(1-2):108-16
pubmed: 21044672
J Zhejiang Univ Sci B. 2011 Oct;12(10):853-61
pubmed: 21960349
Mol Neurobiol. 2012 Oct;46(2):487-94
pubmed: 22865193
Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):406-10
pubmed: 2317321
Otol Neurotol. 2013 Oct;34(8):1496-502
pubmed: 23884329
Neurotoxicology. 2014 Jul;43:21-27
pubmed: 24333467
Lab Anim. 2014 Feb 4;48(3):178-192
pubmed: 24496575
Int J Pediatr Otorhinolaryngol. 2014 Apr;78(4):663-9
pubmed: 24582075
Acta Physiol Pharmacol Latinoam. 1989;39(4):419-30
pubmed: 2520360
Ann Otol Rhinol Laryngol. 2015 Apr;124(4):280-7
pubmed: 25358613
Audiol Neurootol. 2015;20(1):51-61
pubmed: 25428170
Hear Res. 2014 Dec;318:18-22
pubmed: 25456090
J Assoc Res Otolaryngol. 2015 Aug;16(4):459-71
pubmed: 25940139
Arch Otolaryngol. 1973 Jul;98(1):32-7
pubmed: 4713139
Acta Otolaryngol. 1979;88(5-6):369-81
pubmed: 532612
ORL J Otorhinolaryngol Relat Spec. 1978;40(1):53-63
pubmed: 567775
Am J Otolaryngol. 1984 May-Jun;5(3):177-82
pubmed: 6742338
Arch Otolaryngol. 1983 Jan;109(1):22-9
pubmed: 6848102
Biochemistry. 1996 Nov 19;35(46):14659-64
pubmed: 8931565
J Basic Clin Physiol Pharmacol. 1997;8(3):141-55
pubmed: 9429983
Auris Nasus Larynx. 1998 Sep;25(3):223-32
pubmed: 9799987